The Effect of Video Training o Symptom Management With Heart Failure
T The Effect Of Video Training On Symptom Management And Quality Of Life In Patients Over 65 Years Of Age Wıth Heart Failure
1 other identifier
interventional
98
1 country
2
Brief Summary
The purpose of this clinical study is to compare the effect of video-assisted training on the quality of life and symptom management of patients over the age of 65. The main questions it aims to answer are:
- Is there a difference between symptom management and quality of life between the first and last follow-up periods of patients in the application and control groups?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable heart-failure
Started Sep 2022
Shorter than P25 for not_applicable heart-failure
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2023
CompletedFirst Submitted
Initial submission to the registry
September 29, 2023
CompletedFirst Posted
Study publicly available on registry
October 5, 2023
CompletedOctober 5, 2023
September 1, 2023
1 year
September 29, 2023
September 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Heart Failure Symptom Status Scale
It measures the presence, frequency and severity of seven basic symptoms, such as dyspnea during the day, dyspnea when lying down, fatigue, chest pain, edema, sleep problems, dizziness or dizziness, which are the most common in heart failure patients, and the degree to which each of these symptoms affects the patient.When the patient expresses the "zero" option, this indicates that the patient does not have the relevant symptom. To calculate each symptom, all values given by patients for frequency, severity and discomfort are added together. The scores that can be obtained from the scale vary between 0-84.
Three months
Secondary Outcomes (2)
Minnesota Living with Heart Failure Questionnaire
Three months
Michel Uncertainty in Illness Scale - Society Form
Three months
Study Arms (2)
No invention: Control Group
NO INTERVENTIONData collection tools were applied to individuals in the control group on day 0 (Z0), day 30 (Z1) and day 90 (Z2) of follow-up. Data collection tools applied to the control group are as follows: Patient Introduction Form, Heart Failure Symptom Status Scale, Minnesota Living with Heart Failure Questionnaire,Michel Uncertainty in Illness Scale - Community Form.
Experimental: application group
EXPERIMENTALTwo 15-minute training videos (30 minutes in total) prepared for symptom management will be shared on the phones of the patients/relatives in the application group and the patients and their relatives will be informed by watching the training video.Data collection tools were applied to individuals in the application group on day 0 (Z0), day 30 (Z1) and day 90 (Z2) of follow-up. Data collection tools applied to the application group are as follows: Patient Introduction Form, Heart Failure Symptom Status Scale, Minnesota Living with Heart Failure Questionnaire,Michel Uncertainty in Illness Scale - Community Form.
Interventions
After determining the application and control groups in the research, the purpose of the research was explained to both groups. The mobile phone usage skills of the individuals who will be included in the application group were evaluated with the Digital Literacy Scale. Training videos for 15 people each (30 minutes in total) regarding symptom management were shared on the phones of the patients/relatives in the application groups, and the patients and their relatives were informed and watched the training video. Data collection forms would be filled out before the application (Z0), on the 30th day of the application (Z1), and on the 90th day of the application (Z2).
Eligibility Criteria
You may qualify if:
- years and above
- Volunteer to participate in the research
- Diagnosed with heart failure at least six months ago
- He/she/his relative has internet access and can use a smartphone
- Digital literacy scale score over 17
- Class I, II, III according to NYHA classification
You may not qualify if:
- Under 65 years of age
- Known serious vision and hearing problems
- With cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ege Universitylead
Study Sites (2)
Dr. Sadi Konuk Training and Research Hospita
Istanbul, Turkey (Türkiye)
Istanbul Yeni Yüzyıl University Private Gaziosmanpaşa Hospital
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pinar YEL
Ege University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- In the study, groups were determined by block randomization. The randomization list was created by block randomization according to New York Heart Association (NYHA) classification.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
September 29, 2023
First Posted
October 5, 2023
Study Start
September 1, 2022
Primary Completion
September 1, 2023
Study Completion
September 15, 2023
Last Updated
October 5, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share